Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Exagen Expects Q1 FY2024 Revenue Of $13M-$13.5M Versus Consensus Of $11.49M, The Company Says Existing Cash And Cash Equivalents Of $36.5M Will Be Adequate To Meet Anticipated Cash Requirements Into 2026

Author: Benzinga Newsdesk | March 18, 2024 08:09am

Posted In: XGN